腹水评估

Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021 Aug;74(2):1014-48.全文  摘要

Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004 Feb 5;350(6):578-85. 摘要

1. Krige JEJ, Beckingham IJ. Clinical review: ABC of disease of liver, pancreas and biliary system. Portal hypertension-2. Ascites, encephalopathy and other conditions. BMJ. 2001 Feb 17;322(7283):416-8.全文  摘要

2. GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-66.全文  摘要

3. Ginès P, Cardenas A., Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med. 2004 Apr 15;350(16):1646-54. 摘要

4. Sikuler E, Ackerman Z, Braun M, et al. Guidelines for diagnosis and management of cirrhotic ascites and its complications. The Israeli Association for the Study of the Liver [in Hebrew]. Harefuah. 2012 Dec;151(12):705-8. 摘要

5. Royal College of Obstetricians and Gynaecologists. Management of ascites in ovarian cancer patients. Nov 2014 [internet publication].全文

6. Elkassem S, Dixon E, Conly J, et al. Primary peritonitis in a young healthy woman: an unusual case. Can J Surg. 2008 Apr;51(2):E40-1.全文  摘要

7. Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992 Aug 1;117(3):215-20. 摘要

8. Ge PS, Runyon BA. Treatment of patients with cirrhosis. N Engl J Med. 2016 Aug 25;375(8):767-77. 摘要

9. Zhai M, Liu Z, Long J, et al. The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017. Sci Rep. 2021 Mar 4;11(1):5195.全文  摘要

10. Ricart E, Soriano G, Novella MT, et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol. 2000 Apr;32(4):596-602. 摘要

11. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology. 1985 May-Jun;5(3):457-62. 摘要

12. Chen TA, Lo GH, Lai KH, et al. Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. World J Gastroenterol. 2005 Nov 21;11(43):6823-7.全文  摘要

13. Angeli P, Guarda S, Fasolato S, et al. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. Aliment Pharmacol Ther. 2006 Jan 1;23(1):75-84.全文  摘要

14. Strauss E, Caly WR. Spontaneous bacterial peritonitis: a therapeutic update. Expert Rev Anti Infect Ther. 2006 Apr;4(2):249-60. 摘要

15. Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021 Aug;74(2):1014-48.全文  摘要

16. Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021 Jan;70(1):9-29.全文  摘要

17. Akriviadis EA. Hemoperitoneum in patients with ascites. Am J Gastroenterol. 1997 Apr;92(4):567-75. 摘要

18. Tapping CR, Ling L, Razack A. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol. 2012 May;85(1013):623-8.全文  摘要

19. Martin LG. Percutaneous placement and management of the Denver shunt for portal hypertensive ascites. AJR Am J Roentgenol. 2012 Oct;199(4):W449-53.全文  摘要

20. Israelsen M, Krag A, Allegretti AS, et al. Terlipressin versus other vasoactive drugs for hepatorenal syndrome. Cochrane Database Syst Rev. 2017 Sep 27;(9):CD011532.全文  摘要

21. Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008 May;134(5):1360-8.全文  摘要

22. European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 Aug;69(2):406-60.全文  摘要

23. Kim WR, Brown RS Jr, Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul;36(1):227-42. 摘要

24. Blachier M, Leleu H, Peck-Radosavljevic M, et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013 Mar;58(3):593-608. 摘要

25. Cattau E, Benjamin SB, Knuff TE, et al. The accuracy of the physical exam in the diagnosis of suspected ascites. JAMA. 1982 Feb 26;247(8):1164-6. 摘要

26. Light, RW. Clinical practice. Pleural effusion. N Engl J Med. 2002 Jun 20;346(25):1971-7. 摘要

27. Inadomi J, Cello JP, Koch J. Ultrasonographic determination of ascitic fluid. Hepatology. 1996 Sep;24(3):549-51. 摘要

28. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003 Jul;38(1):258-66. 摘要

29. Krige JE, Beckingham IJ. Clinical review: ABC diseases of liver, pancreas and biliary system. Portal hypertension - 1: varices. BMJ. 2001 Feb 10;322(7282):348-51.全文  摘要

30. Sakai H, Sheer TA, Mendler MH, et al. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005 Oct;25(5):984-6. 摘要

31. Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther. 2005 Mar 1;21(5):525-9.全文  摘要

32. Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986 Nov;146(11):2259-61. 摘要

33. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991 Feb;31(2):164-71. 摘要

34. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.全文  摘要

35. Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021 Jan;70(1):9-29.全文  摘要

36. Wong CL, Holroyd-Leduc J, Thorpe KE, et al. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA. 2008 Mar 12;299(10):1166-78.全文  摘要

37. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32(1):142-53. 摘要

38. Bernardi M, Carceni P, Navickis RJ, et al. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012 Apr;55(4):1172-81.全文  摘要

39. Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017 Jan;65(1):310-35. 摘要

40. Walsh K, Alexander G. Alcoholic liver disease. Postgrad Med J. 2000 May;76(895):280-6.全文  摘要

41. Runyon BA. Cardiac ascites: a characterization. J Clin Gastroenterol. 1988 Aug;10(4):410-2. 摘要

42. Orth SR. Ritz E. The nephrotic syndrome. N Engl J Med. 1998 Apr 23;338(17):1202-11. 摘要

43. Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416. 摘要

44. American Society for Clinical Pathology. Do not test for amylase in cases of suspected acute pancreatitis. Instead, test for lipase. 14 Sep 2016 [internet publication].全文

45. Rompianesi G, Hann A, Komolafe O, et al. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis. Cochrane Database Syst Rev. 2017 Apr 21;(4):CD012010.全文  摘要

46. Aggarwal R, Ranjan P. Clinical review: preventing and treating hepatitis B infection. BMJ. 2004 Nov 6;329(7474):1080-6.全文  摘要

47. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005 Sep 22;353(12):1261-73. 摘要

48. Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019 Jan;69(1):394-419. 摘要

49. Ryder SD, Beckingham IJ. ABC of diseases of liver pancreas and biliary system. Other causes of parenchymal liver disease. BMJ. 2001 Feb 3;322(7281):290-2.全文  摘要

50. Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med. 2004 Jun 3;350(23):2383-97. 摘要

51. Ryan A, Nevitt SJ, Tuohy O, et al. Biomarkers for diagnosis of Wilson's disease. Cochrane Database Syst Rev. 2019 Nov 19;2019(11):CD012267.全文  摘要

52. Nishimura RA. Constrictive pericarditis in the modern era: a diagnostic dilemma. Heart. 2001 Dec;86(6):619-23.全文  摘要

53. Osterberg L, Vagelos R, Atwood JE. Case presentation and review: constrictive pericarditis. West J Med. 1998 Oct;169(4):232-9.全文  摘要

54. Oren RM, Grover-McKay M, Stanford W, et al. Accurate preoperative diagnosis of pericardial constriction using cine computed tomography. J Am Coll Cardiol. 1993 Sep;22(3):832-8.全文  摘要

55. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004 Feb 5;350(6):578-85. 摘要

56. Wood ML, Foulds IS, French MA. Protein losing enteropathy due to systemic lupus erythematosus. Gut. 1984 Sep;25(9):1013-5.全文  摘要

57. Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005 Feb 8;2(1):3.全文  摘要

58. Turlakow A, Yeung HW, Salmon AS, et al. Peritoneal carcinomatosis: role of 18F-FDG PET. J Nucl Med. 2003 Sep;44(9):1407-12.全文  摘要

59. Ross AG, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med. 2002 Apr 18;346(16):1212-20. 摘要

60. Mills JA. Systemic lupus erythematosus. N Engl J Med. 1994 Jun 30;330(26):1871-9. 摘要

61. Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003 Sep;96(9):623-33. 摘要

62. Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg. 1996 Jul;224(1):10-8.全文  摘要

63. al Karawi MA, Mohamed AE, Yasawy MI, et al. Protean manifestation of gastrointestinal tuberculosis: report on 130 patients. J Clin Gastroenterol. 1995 Apr;20(3):225-32. 摘要

64. Ravdin IS, Morrison ME, Smyth CM. Bile peritonitis and bile ascites. Ann Surg. 1929 Jun;89(6):867-77.全文  摘要